postpartum visit within 12 weeks of delivery and those missing information regarding PPD were excluded. Primary outcome was postpartum depression; classified as an Edinburgh Postnatal Depression Scale(EPDS) score >13/30 or provider report of PPD in absence of documented EPDS. Bivariate statistics used to compare demographics, pregnancy & obstetric complications, and neonatal factors of women with gestational weight gain less than the Institute of Medicine(IOM) guidelines(<11lbs) (LT11) with those who gained at or more than IOM guidelines (GT11). Stepwise backward regression used to estimate odds of primary outcome. Correlation between GWG and EPDS was assessed. RESULTS: Of 275 included, 96 (34.9%) gained LT11 and 179 (65.1%) gained GT11. Women who gained LT11 had higher median baseline BMI (46.2 vs 43.2) and be multiparous (both p<0.01). The LT11 cohort had lower median delivery BMI (47.9 vs 45.7), and larger median total weight change (-15 vs 2) (both p<0.01). Other demographic, antepartum, intrapartum, and postpartum complications did not differ ( Table 1) .
Little is known about its effects on pregnancy. The objective of this study was to evaluate the pregnancy outcomes in women suffering from EDS. STUDY DESIGN: We conducted a population-based, retrospective cohort study using the United States' Health Care Cost and Utilization Project's Nationwide Inpatient Sample to evaluate pregnancy outcomes in women with EDS, compared to those without EDS, delivering between 1999 and 2013. We used unconditional regression analysis, adjusted for maternal age and race, to compare maternal and fetal outcomes among pregnancies in women with and without EDS. RESULTS: Of the total 13,881,592 births in our cohort, 910 deliveries were to women with EDS. Women with EDS were more likely to be Caucasian, earn a higher income, and smoke. Births to women with EDS were more likely to be premature (OR 1.51 (95% CI 1.20-1.89)). Pregnancies complicated by EDS were more likely to be associated with cervical incompetence (OR 3.22 (95% CI 2.04-5.07)), antepartum hemorrhage (OR 1.79 (95% CI 1.20-2.66)) and placenta previa (OR 2.23 (95% CI 1.29-3.86)). Pregnant women with EDS were also more likely to be delivered by cesarean section (OR 1.61 (95% CI 1.41-1.85)), as well as stay longer than 7 days in the hospital (OR 3.10 (95% CI 2.34-4.09)). CONCLUSION: Pregnant women with EDS are at higher risk of antepartum hemorrhage, placenta previa, cervical incompetence and preterm birth, as well as delivering by cesarean section, when compared to women without EDS. These risks should be taken into consideration and cervical surveillance should be considered. and analysis, and best practices such as safety huddles for laborists and nurses. Data was extracted from an integrated electronic medical record for analysis. RESULTS: An average of 3700 of births/year took place during this time period with community practitioners attending the majority of births. The total CS rate and the primary CS rates decreased while the Vaginal Birth After CS (VBAC) rate increased (Table 1, Figure 1) . The elective (non-medically indicated) induction of labor prior to 39 weeks was reduced to 0%. The decline in the CS rate from 30% to 20% led to an overall reduction of w400 Cesarean deliveries per year. CONCLUSION: The full-time laborist program initially alarmed the community practitioners; however, hospital champions facilitated discussions between laborists, MFMs, community physicians, midwives, nurses, and patients about timing of scheduled births, management of high risk pregnancies, VBAC, and ECV. The culture shifted on the unit to promote patient safety, quality, and best practices while supporting professional satisfaction of the community practitioners in private practice, residency training, and the faculty practices.
576 Opioid detoxification during pregnancy to prevent neonatal abstinence syndrome Laurie Scott, Claudia P. Vicencio, Alberto Augsten, Tammy L. Tucker Memorial Healthcare System, Hollywood, FL OBJECTIVE: The increase in maternal opioid use disorder (OUD) has led to an increase in neonatal abstinence syndrome (NAS). Medication assisted treatment (MAT) is recommended for OUD in pregnancy due to possible relapse to illicit substance use after withdrawal in up to 90%, and concern regarding the fetal safety of opioid withdrawal. However, many opioid dependent pregnant women are motivated to end their dependency and avoid NAS for their babies. For these women, medically supervised withdrawal (MSW) may be beneficial.
